Literature DB >> 6108395

Deficit of suppressor T cells in active multiple sclerosis.

M A Bach, F Phan-Dinh-Tuy, E Tournier, L Chatenoud, J F Bach, C Martin, J D Degos.   

Abstract

Suppressor T cells in forty-seven patients with multiple sclerosis (MS) were studied by indirect immunofluorescence by means of monoclonal antibodies directed at T-cell subsets. Suppressor cell numbers were depressed in patients with acute exacerbation of MS and in patients with continuous progressive deterioration. In one case the T-cell anomaly was observed one week before the onset of the acute phase; it had been absent 4 months before exacerbation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108395     DOI: 10.1016/s0140-6736(80)92480-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  58 in total

1.  Serial studies of evoked potentials and circulating lymphocyte subsets for multiple sclerosis: attempts to monitor progress.

Authors:  H M Chapel; M Small; S Gregory; W B Matthews
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

2.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  T-lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity.

Authors:  M Prencipe; E Salerni; C D'Aurizio; C Marini; D Adorno; A M Berghella; P Pellegrini; F Papola; C U Casciani
Journal:  Ital J Neurol Sci       Date:  1986-12

4.  The role of the thymus in multiple sclerosis.

Authors:  V D'Andrea; G Meco; F Corvese; P F Baselice; V Ambrogi
Journal:  Ital J Neurol Sci       Date:  1989-02

5.  Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.

Authors:  R N Mshana; A Haregewoin; A Belehu
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

6.  Impairment of T lymphocyte functions in mice with motor end-plate disease.

Authors:  M Papiernik; F Rieger; S Ezine; M Pincon-Raymond
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

7.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.

Authors:  S Fredrikson; P Eneroth; H Link
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  Effect of lymphocytapheresis plus cyclophosphamide on the course of a chronic progressive form of multiple sclerosis.

Authors:  S Ferla; G Meneghetti; S Spartà; M Belloni; G Ongaro
Journal:  Ital J Neurol Sci       Date:  1985-09

10.  Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis.

Authors:  M Zaffaroni; D Caputo; A Ghezzi; S Marforio; C L Cazzullo
Journal:  Ital J Neurol Sci       Date:  1984-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.